Stock Movers

On this episode of Stock Movers:
- Nvidia (NVDA) is working on AI infrastructure deals potentially worth more than $750 billion, including an artificial intelligence initiative with SK Hynix Inc.'s parent worth more than $500 billion. The deals have raised concerns about circular financing and skewed incentives, with critics warning that they may artificially inflate demand and valuations across the industry and create systemic shocks.
- Ford Motor (F) shares gain. Jefferies upgraded Ford to buy from hold ahead of second quarter earnings report. Analyst Philippe Houchois says “there is always scope for surprise either way at Ford, but we see Q2 as a low point for volume with post-Novelis production set to normalize up.”
- ExxonMobil (XOM) shares fall. Energy stocks drop after the US and Iran held off on attacks for a third straight night, sending oil prices lower. Airlines and cruise lines rally.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Forte Bioscience (FBRX) is soaring as Argenx SE agreed to buy Forte Biosciences Inc. for about $2.2 billion in cash to expand its portfolio of immunology medicines.
- Astrazeneca (AZN) shares after it reported higher-than-expected profit, buoyed by blockbuster cancer medicines, with earnings per share rising 21% to $2.63 last quarter.
- Paramount Skydance (PSKY) shares are reacting to news that it paused its blockbuster deal for Warner Bros.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Nvidia (NVDA) shares are moving on a report from the Wall Street Journal that Nvidia is in talks to provide a roughly $250 billion backstop for OpenAI as part of a massive data center project. The guarantees from Nvidia would help the ChatGPT maker lease a 10-gigawatt project that SoftBank is developing in southern Ohio.
- Forte Bioscience (FBRX) is soaring as Argenx SE agreed to buy Forte Biosciences Inc. for about $2.2 billion in cash to expand its portfolio of immunology medicines.
- AT&T (T) is moving on news it has opened books on a at least €2 billion euro and sterling bond offering.
- Trip.com Group (TCOM) shares are responding to news it received an administrative penalty decision from China’s State Administration for Market Regulation, ordering the company to halt antitrust violations, refund hotel operators and pay a fine of 3.52 billion yuan ($520 million), according to a Hong Kong exchange filing.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- AstraZeneca reported higher-than-expected profit, buoyed by blockbuster cancer medicines, as focus turns to the company’s next generation of oncology drugs.
- Vodafone reported first-quarter service revenue growth that beat analysts’ estimates after sales increased in Germany, the phone carrier’s largest market.
- Pinewood Technologies shares rise as much as 35% after US buyout firm Ridgeview made a cash offer valuing the UK car dealership software provider at ~£545 million.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- The FTSE 100 is rising as the global equity mood turns more positive, although the bluechip benchmark is underperforming European stocks thanks to a drag from heavyweight oil firms Shell and BP.
- Vodafone reported first-quarter service revenue growth that beat analysts’ estimates after sales increased in Germany, the phone carrier’s largest market.
- Zabka shares fell as much as 13%, the most on record, after Seven & i abandoned plans to buy an equity stake in the Polish convenience-store operator. The stock found support around its 50-day moving average at PLN26.90
See omnystudio.com/listener for privacy information.